Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid

BACKGROUND: Early and accurate detection and staging is critical to managing Alzheimer’s disease (AD) and supporting clinical trials. Cerebrospinal fluid (CSF) biomarkers for amyloid-β peptides, tau species, and various neurodegenerative and inflammatory analytes are leading the way in this regard,...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Alzheimers Dis
Main Authors: Triana-Baltzer, Gallen, Van Kolen, Kristof, Theunis, Clara, Moughadam, Setareh, Slemmon, Randy, Mercken, Marc, Galpern, Wendy, Sun, Hong, Kolb, Hartmuth
格式: Artigo
語言:Inglês
出版: IOS Press 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683057/
https://ncbi.nlm.nih.gov/pubmed/32831201
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200463
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍